American Journal of Clinical Pathology · 2013 · 59 citations · 21 references
MedicineHematologyPathologyCellular PathologyHematologic OncologyHematopathologyHematologic MalignanciesHematologic PathologyLymphoid NeoplasmsLymphoid TumorsTumor ClassificationB-cell DisordersB-cell LeukemiaFlow Cytometric AnalysisFlow Cytometric ImmunophenotypingImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingLymphoplasmacytic Lymphoma
OBJECTIVES: To evaluate CD200 expression in B-cell proliferative disorders. METHODS: We analyzed 180 recent specimens of B-cell neoplasms for CD200 expression by flow cytometric immunophenotypic analysis, which is better able to assess relative intensity of staining than immunohistochemical staining. RESULTS: We found that hairy cell leukemia exhibits a high level of staining for CD200 in comparison to other B-cell lymphoproliferative disorders, including hairy cell leukemia-variant (HCL-V), marginal zone lymphoma, and lymphoplasmacytic lymphoma. We confirmed this observation by semiquantitative immunohistochemical staining. CONCLUSIONS: Assessment of the CD200 expression level is helpful to distinguish HCL from HCL-V and other B-cell lymphoproliferative disorders and in the differential diagnosis of B-cell neoplasms in general.
21
Down-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)
Robert M. Hoek, Sigrid R. Ruuls, Craig A. Murphy et al. · Science · 2000 · 1K citations
CD200 is a new prognostic factor in multiple myeloma
Jérôme Moreaux, Dirk Hose, Thierry Rème et al. · Blood · 2006 · 230 citations · Full text
Medicine, Hematology, Oncology +13